Geneos Wealth Management’s FT Vest U.S. Equity Max Buffer ETF - November NOVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$410K Hold
11,980
– – 0.01% 850
2026
Q2
$404K Buy
11,980
+5,990
+100% +$200K 0.01% 803
2026
Q1
$196K Sell
5,990
-250
-4% -$8.23K ﹤0.01% 965
2025
Q4
$205K Hold
6,240
– – 0.01% 917
2025
Q3
$201K Hold
6,240
– – 0.01% 904
2025
Q2
$196K Sell
6,240
-10
-0.2% -$308 ﹤0.01% 1005
2025
Q1
$190K Hold
6,250
– – 0.01% 926
2024
Q4
$191K Buy
+6,250
New +$192K 0.01% 855

Other funds holding NOVM

Geneos Wealth Management's NOVM Position: Q3 2026 in Review

Geneos Wealth Management held its FT Vest U.S. Equity Max Buffer ETF - November (NOVM) position steady in Q3 2026 at 11,980 shares worth $410K. The position accounts for 0.01% of the portfolio, ranked #850.

Geneos Wealth Management first reported a position in NOVM in Q4 2024 and has held it in 8 quarters since. 26 funds tracked by Wall St. Rank hold NOVM as of Q3 2026.

  • Geneos Wealth Management held 11,980 shares of FT Vest U.S. Equity Max Buffer ETF - November worth $410K as of Q3 2026.
  • Geneos Wealth Management left its FT Vest U.S. Equity Max Buffer ETF - November share count unchanged in Q3 2026.
  • FT Vest U.S. Equity Max Buffer ETF - November made up 0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #850 holding.
  • Geneos Wealth Management first reported a position in FT Vest U.S. Equity Max Buffer ETF - November in Q4 2024 and has held it in 8 quarters since.
  • 26 funds tracked by Wall St. Rank held FT Vest U.S. Equity Max Buffer ETF - November as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.